Status:
COMPLETED
Monitored Anesthesia Care With Propofol Plus Remifentanil During Endoscopic Submucosal Dissection: Evaluation of Bispectral Index Monitoring
Lead Sponsor:
Yonsei University
Conditions:
Early Gastric Cancer
Eligibility:
All Genders
40-70 years
Phase:
NA
Brief Summary
There are clinical usefulness issues associated with bispectral index (BIS) for sedation of endoscopic submucosal dissection (ESD). However, the clinical usefulness of BIS for deep sedation is incompl...
Eligibility Criteria
Inclusion
- American Society of Anesthesiologists (ASA) physical status I to II.
Exclusion
- body mass index (BMI) over 35 (Kg/m2)
- hepatic or renal insufficiency
- history of allergy to the drugs used
- history of administration of anxiolytics, narcotics, antipsychotics, opioid.
Key Trial Info
Start Date :
September 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2012
Estimated Enrollment :
180 Patients enrolled
Trial Details
Trial ID
NCT01921283
Start Date
September 1 2011
End Date
February 1 2012
Last Update
August 13 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Anesthesiology and Pain Medicine
Seoul, Seoul, South Korea, 120-752